#USA #Dallas #Neurostimulation #Spark Biomedical #Bioelectronic

Spark Biomedical Strengthens Leadership Team

Spark Biomedical, a leader in the bioelectronic medicine space known for its innovative approach to non-invasive neurostimulation, has taken a significant step in enhancing its commercial posture by fortifying its executive team. The recent announcement heralds the addition of three seasoned professionals—Ric Peterson, Tom Futch, and Jeff Jones—each bringing a wealth of experience and expertise that promises to propel the company toward greater market success.

New Strategic Leadership for Growth

With an ambitious roadmap focusing on expanding manufacturing capabilities and advancing multi-channel sales, Spark Biomedical is poised for a dynamic transformation under the guidance of these new leaders. Anja Krammer, CEO of Spark, expressed optimism about the new team, stating, “This leadership will build on the solid foundation established by our founders, enhancing our ability to drive commercial success.” This optimism underscores the importance of aligning exceptional talent with the company’s strategic priorities to achieve sustainable growth.

Meet the New Executives

1. Ric Peterson – Chief Financial Officer
Ric Peterson joins Spark as a capital-markets-oriented CFO, bringing a notable track record in finance, investor relations, and business development from his previous roles, including a key position at Medicis Pharmaceutical. His insights from guiding companies through initial public offerings (IPOs) and capital raises will be invaluable as Spark seeks to solidify its financial frameworks in preparation for expansion.

2. Tom Futch – Executive Vice President of Growth
With over two decades in the industry, Tom Futch has been instrumental in cultivating commercial growth in various health technology sectors, including roles at large medical device firms such as Johnson & Johnson and Medtronic. His expertise in creating go-to-market strategies, particularly within wearables and digital health, will greatly benefit Spark as it aims to enhance its presence across multiple channels.

3. Jeff Jones – Executive Vice President of Manufacturing Operations
An executive with extensive experience in scaling manufacturing processes, Jeff Jones will focus on transitioning Spark’s products from prototype stages to high-volume production. His operational prowess from previous leadership roles in companies like Neuronetics and Cutera aligns perfectly with Spark's need to enhance manufacturing capabilities for its product lines.

4. Amy Gaston – Vice President of Marketing
Additionally, Amy Gaston has been elevated to lead marketing strategies across Spark’s comprehensive Neuro-Behavioral, Neuro-Vascular, and Neuro-Immune product offerings. Having previously established successful partnerships within the industry, her leadership will be pivotal in enhancing brand visibility and advocacy across Spark’s expanding market.

A Commitment to Innovation

The original founders, Navid Khodaparast and Alejandro Covalin, will continue to spearhead clinical evidence and innovation for Spark’s products, including the Sparrow Ascent® and HAWK platforms. The synergy created by combining commercial, financial, and manufacturing strengths alongside scientific expertise forms a robust basis for achieving FDA clearance and reimbursement pathways, which are pivotal for the success of any medical device company.

About Spark Biomedical

Headquartered in Dallas, Texas, Spark Biomedical is at the forefront of developing groundbreaking bioelectronic therapies using its proprietary tAN® (transcutaneous auricular neurostimulation) technology. This platform seeks to address a variety of conditions within Neuro-Behavioral Health, Neuro-Vascular, and Neuro-Immune domains, reinforcing Spark's commitment to innovation within the medical device landscape.

As the company strides forward with its newly expanded leadership, Spark Biomedical is gearing up to enhance its product offerings and market reach significantly, setting the stage for a transformative era in bioelectronic medicine.